Companies
Neuralink
NeuralinkSan Francisco, CA
Founded 2016
Healthcare
Last Round Valuation
$9.65B
Last Round Share Price
$ XX.XY
Total Funding
$1.29B
Last Round
Series E
Neuralink
$64.93
1M
3M
YTD
1Y
2Y
MAX
Funding Rounds
Nothing here |
Information contained herein is based on estimates and is subject to update.
News
06/25/2025
Neuralink Achieves Milestone in Brain-Computer Interface Technology with Live Demonstration
Neuralink's live demonstration of brain-computer interface technology not only advances neurotechnology but also raises critical ethical and regulatory questions that could shape the future of human-computer interaction and medical treatments.
06/14/2025
Neuralink's Blindsight Technology Set to Begin Human Trials for Vision Restoration
Neuralink's human trials for vision restoration could revolutionize treatment for blindness, potentially reshaping healthcare markets and driving advancements in neurotechnology and patient care.
06/04/2025
Neuralink Secures $650 Million Funding to Advance Brain-Computer Interface Technologies
Neuralink's $650 million funding not only accelerates brain-computer interface innovation but also positions the company as a frontrunner in a burgeoning market that could redefine human-computer interaction and healthcare solutions.
Research
Research reports obtained through third party are for informational purposes only.
Let us know if we are missing anything
FAQ
What is Augment?
Does Augment protect my privacy?
Who can use Augment?
Does my company allow sales of shares?
Which companies are listed on Augment’s marketplace?
What is required to join Augment?
How can I get notified when there are new interested buyers of my shares?
Are orders posted anonymously?
How do Augment fees work?
How do I know what price to buy or sell shares?
What size transactions does Augment support?
How do I know if an order is created by a broker or a direct buyer or user?
Is trading on Augment safe and legitimate?
What is the typical process of selling shares?
